143 related articles for article (PubMed ID: 25326185)
1. Knockdown of PPP5C inhibits growth of hepatocellular carcinoma cells in vitro.
Feng L; Sun P; Li Z; Liu M; Sun S
Appl Biochem Biotechnol; 2015 Jan; 175(1):526-34. PubMed ID: 25326185
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of protein phosphatase 5 (PPP5C) suppresses the growth of leukemic cell line U937.
Li GY; Liu JZ; Zhang L; Li SJ; Liu GZ; Xiao TW; Wang JX; Wang LX; Hou M
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):27-31. PubMed ID: 27755948
[TBL] [Abstract][Full Text] [Related]
3. Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.
Chen M; Lv JM; Ye JQ; Cui XG; Qu FJ; Chen L; Liu X; Pan XW; Li L; Huang H; Yang QW; Chen J; Wang LH; Gao Y; Xu DF
Int J Oncol; 2017 Jul; 51(1):39-48. PubMed ID: 28534961
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of RRS1 by lentiviral-mediated RNAi promotes apoptosis and suppresses proliferation of human hepatocellular carcinoma cells.
Wang J; Li Z; Zuo C; Xie Q; Li H; Jia J; Zhen Z; Qi R; Li Z; Liu D; Sun B
Oncol Rep; 2017 Oct; 38(4):2166-2172. PubMed ID: 28849112
[TBL] [Abstract][Full Text] [Related]
5. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
6. Serine/Threonine Protein Phosphatase-5 Accelerates Cell Growth and Migration in Human Glioma.
Zhi X; Zhang H; He C; Wei Y; Bian L; Li G
Cell Mol Neurobiol; 2015 Jul; 35(5):669-77. PubMed ID: 25796168
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of ribosomal protein S15A mRNA with a short hairpin RNA inhibits human hepatic cancer cell growth in vitro.
Xu M; Wang Y; Chen L; Pan B; Chen F; Fang Y; Yu Z; Chen G
Gene; 2014 Feb; 536(1):84-9. PubMed ID: 24334120
[TBL] [Abstract][Full Text] [Related]
8. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.
Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Guan W; Zhou J; Wu Y; Qiu Y; Ding Y
Oncol Rep; 2015 Aug; 34(2):823-32. PubMed ID: 26081192
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
[TBL] [Abstract][Full Text] [Related]
10. shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.
Zhang D; Liu J; Wang Y; Chen J; Chen T
J Cell Biochem; 2011 Nov; 112(11):3140-50. PubMed ID: 21695716
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of G protein-coupled receptor 137 by RNA interference inhibits cell growth of two hepatoma cell lines.
Shao X; Liu Y; Huang H; Zhuang L; Luo T; Huang H; Ge X
Cell Biol Int; 2015 Apr; 39(4):418-26. PubMed ID: 25490967
[TBL] [Abstract][Full Text] [Related]
12. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
[TBL] [Abstract][Full Text] [Related]
13. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells.
Lan X; Wu YZ; Wang Y; Wu FR; Zang CB; Tang C; Cao S; Li SL
Int J Mol Med; 2013 Feb; 31(2):315-24. PubMed ID: 23233126
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells.
Yu YS; Tang ZH; Pan QC; Chen XH; Liu XN; Zang GQ
Cancer Chemother Pharmacol; 2012 May; 69(5):1173-80. PubMed ID: 22237956
[TBL] [Abstract][Full Text] [Related]
15. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells.
Yu MM; Feng YH; Zheng L; Zhang J; Luo GH
World J Gastroenterol; 2019 Mar; 25(10):1210-1223. PubMed ID: 30886504
[TBL] [Abstract][Full Text] [Related]
16. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression.
Hu B; Yan X; Liu F; Zhu C; Zhou H; Chen Y; Liu J; Gu X; Ni R; Zhang T
Pathol Oncol Res; 2016 Jul; 22(3):555-65. PubMed ID: 26715439
[TBL] [Abstract][Full Text] [Related]
17. shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferation.
Yao Z; Hu K; Huang H; Xu S; Wang Q; Zhang P; Yang P; Liu B
Int J Mol Med; 2015 Nov; 36(5):1393-9. PubMed ID: 26397132
[TBL] [Abstract][Full Text] [Related]
18. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
[TBL] [Abstract][Full Text] [Related]
19. Silencing of hypoxia‑inducible adrenomedullin using RNA interference attenuates hepatocellular carcinoma cell growth in vivo.
Li F; Yang R; Zhang X; Liu A; Zhao Y; Guo Y
Mol Med Rep; 2014 Sep; 10(3):1295-302. PubMed ID: 24927229
[TBL] [Abstract][Full Text] [Related]
20. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
